Analysis of the histopathological changes in patients with AD has shown that tau inclusions correlate much better with cognitive impairment than amyloid plaques (Nelson et al., 2012) suggesting a major role of changes in tau expression and phosphorylation for disease development. The gene discussed is MAPT; the disease is Cognitive impairment.